Jeffrey Scott Wefel MD, PhD, ABPP

Dr. Wefel is a board-certified neuropsychologist, Associate Professor, and Neuropsychology Section Chief in the Department of Neuro-Oncology. He maintains an active consultation-liaison service where he conducts comprehensive neuropsychological assessments, presurgical fMRI of higher-order cognitive function for neurosurgical planning, and offers interventions to adult cancer patients suffering from the central nervous system effects of cancer, cancer treatment, or other illnesses. 

Dr. Wefel's research activities seek to characterize the prevalence, pattern, course, risks, and biologic and neural substrates for the development of neurocognitive dysfunction associated with cancer and cancer therapies. Ultimately, this will lead to the identification and testing of interventions to prevent and/or minimize cognitive dysfunction. He is the neurocognitive study chair on numerous cooperative group, industry-sponsored and investigator-initiated trials involving patients with breast cancer, brain tumor, and brain metastasis, many of which integrate cognitive and neuroimaging outcomes as well as an exploration of genetic moderators of cognitive and brain outcomes.